Vroom Inc. released its Q4 financial results on March 13, 2024, impacting its stock performance significantly. Here is a breakdown...

Cue Health (NASDAQ: HLTH) released its Q4 earnings on March 13, 2024, revealing some key highlights: - Earnings: Cue Health...

On March 13, 2024, Poseida Therapeutics received Orphan Drug Designation from the FDA for their innovative treatment, P-BCMA-ALLO1, targeting Multiple...

Needham analyst Serge Belanger has reiterated his Buy rating and $28 price target for Liquidia (NASDAQ:LQDA) on March 13, 2024....

scPharmaceuticals (NASDAQ: SCPH) announced their fourth-quarter 2023 financial results on March 13, 2024. The company reported a GAAP EPS of...

Fossil Group, Inc. underwent significant leadership changes on March 13, 2024. Jeffrey N. Boyer was appointed as the Interim CEO...

Inventiva, a leading biopharmaceutical company, is set to unveil the outcomes of the groundbreaking LEGEND Phase IIa trial featuring a...

Investing in Intuitive Surgical (NASDAQ: ISRG) has been a game-changer for those who took the leap 10 years ago. With...

According to recent data, big-money traders are predominantly bearish on Nucor (NYSE:NUE), with a split sentiment of 25% bullish and...

On March 13, 2024, Warren Wang stepped into the role of Chief Executive Officer and Chairman of the Board at...